Sorabjee J.S., Garje R. Reactivation of old scars: inevitably sarcoid // Postgrad. Med. J. 2005. Vol. 81. N. 951. P. 60–61.
Stern B.J., Royal W. 3rd, Gelfand J.M. et al. Definition consensus diagnostic criteria for neurosarcoidosis: from the neurosarcoidosis Consortium Consensus Group // JAMA Neurol. 2018. Vol. 75. N. 12. P. 1546–1553. DOI: https://doi.org/10.1001/jamaneurol.2018.2295.
Suzuki T., Tsushima K., Kawata N. et al. Estimation using the impulse oscillation system in patients with pulmonary sarcoidosis // Sarcoidosis Vasc. Diffuse Lung Dis. 2015. Vol. 32. N. 2. P. 144–150.
Taimeh Z., Hertz M.I., Shumway S., Pritzker M. Lung transplantation for pulmonary sarcoidosis. Twenty-five years of experience in the USA // Thorax. 2016. Vol. 71. N. 4. P. 378–379. DOI: https://doi.org/10.1136/thoraxjnl-2015-207497.
Tejera Segura B., Holgado S., Mateo L. et al. Löfgren syndrome: a study of 80 cases // Med. Clin. (Barc.). 2014. Vol. 143. N. 4. P. 166–169. DOI: https://doi.org/10.1016/j.medcli.2014.02.029.
Terwiel M., van Moorsel C.H.M. Clinical epidemiology of familial sarcoidosis: a systematic literature review // Respir. Med. 2019. Vol. 149. P. 36–41. DOI: https://doi.org/10.1016/j.rmed.2018.11.022.
Thomeer M., Demedts M., Vandeurzen K. et al. Registration of interstitial lung diseases by 20 centres of respiratory medicine in Flanders // Acta Clin. Belg. 2001. Vol. 56. N. 3. P. 163–172.
Ungprasert P., Matteson E.L. Neurosarcoidosis // Rheum. Dis. Clin. North Am. 2017. Vol. 43. N. 4. P. 593–606. DOI: https://doi.org/10.1016/j.rdc.2017.06.008. Epub 2017 Aug 23.
Utz J.P., Limper A.H., Kalra S. et al. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis // Chest. 2003. Vol. 124. N. 1. P. 177–185.
Van Dee L., Stehouwer M., van Bemmel T. Systemic sarcoidosis associated with exposure to Borrelia burgdorferi in a 21-year-old man // Eur. J. Case. Rep. Intern. Med. 2018. Vol. 5. N. 10. Article ID 000942. DOI: https://doi.org/10.12890/2018_000942.
Van Schalkwyk E.M., Bezuidenhout J., Wyser C.P. et al. Comparison of bronchoalveolar lavage, open lung biopsy and lung function in sarcoidosis // Eur. Respir. J. 1997. Vol. 10. Suppl. 25. Ref. 1357. P. 206s.
Vorselaars A.D., Cremers J.P., Grutters J.C., Drent M. Cytotoxic agents in sarcoidosis: which one should we choose? // Curr. Opin. Pulm. Med. 2014. Vol. 20. N. 5. P. 479–487.
Wanat K.A., Rosenbach M. Cutaneous sarcoidosis // Clin. Chest Med. 2015. Vol. 36. N. 4. P. 685–702.
Wells A.U., Hirani N.; and on behalf of the British Thoracic Society Interstitial Lung. Interstitial lung disease guideline: the British and the Irish Thoracic Society of Australia and New Zealand Thoracic Society in collaboration with the Thoracic Society of Australia and Disease Guideline Group, a subgroup of the British Thoracic Society Standards // Thorax. 2008. Vol. 63. P. v1–v58.
Yablonsky P., Kusnetsov I., Pishchik V. et al. Differential diagnosis of mediastinal lymphoadenopathy // Eur. Respir. J. 2000. Vol. 16. Suppl. 31. Ref. 5731.
Zabel P., Entzian P., Dalhoff K., Schlaak M. Pentoxifylline in treatment of sarcoidosis // Am. J. Respir. Crit. Care Med. 1997. Vol. 155. N. 5. P. 1665–1669.
Zhao M.M., Du S.S., Li Q.H. et al. High throughput 16SrRNA gene sequencing reveals the correlation between Propionibacterium acnes and sarcoidosis // Respir. Res. 2017. Vol. 18. N. 1. P. 28. DOI: https://doi.org/10.1186/s12931-017-0515-z.
&hide_Cookie=yes)